Literatur
-
1
Anderson E A, Sinkey C A, Lawton W J, Mark A L.
Elevated
sympathetic nerve activity in borderline hypertensive humans. Evidence
from direct intraneural recordings.
Hypertension.
1989;
14
177-183
-
2
Brock J A, Van Helden D F, Dosen P, Rush R A.
Prevention of
high blood pressure by reducing sympathetic innervation in the spontaneously hypertensive
rat.
J Auton Nerv Syst.
1996;
61
97-102
-
3
Brown M J, Macquin I.
Is adrenaline the cause
of essential hypertension?.
Lancet.
1981;
2
1079-1082
-
4
Chun L L, Patterson P H.
Role of
nerve growth factor in the development of rat sympathetic neurons
in vitro. II. Developmental studies.
J Cell Biol.
1977;
75
705-711
-
5
Clemow D B, Spitsbergen J M, McCarty R, Steers W D, Tuttle J B.
Arterial nerve growth factor (NGF)
mRNA, protein, and vascular smooth muscle cell NGF secretion in
hypertensive and hyperactive rats.
Exp Cell Res.
1998;
244
196-205
-
6
Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G.
Overflow of catecholamine
neurotransmitters to the circulation: source, fate, and functions.
Physiol
Rev.
1990;
70
963-985
-
7
Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G.
Assessment of human sympathetic
nervous system activity from measurements of norepinephrine turnover.
Hypertension.
1988;
11
3-20
-
8
Esler M, Kaye D, Lambert G, Esler D, Jennings G.
Adrenergic
nervous system in heart failure.
Am J Cardiol.
1997;
80
7L-14L
-
9
Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P.
Norepinephrine kinetics in
essential hypertension. Defective neuronal uptake of norepinephrine
in some patients.
Hypertension.
1981;
3
149-156
-
10
Ferrier C, Jennings G L, Eisenhofer G, Lambert G, Cox H S, Kalff V, Kelly M, Esler M D.
Evidence for
increased noradrenaline release from subcortical brain regions in
essential hypertension.
J Hypertens.
1993;
11
1217-1227
-
11
Floras J S, Hara K.
Sympathoneural and haemodynamic
characteristics of young subjects with mild essential hypertension.
J
Hypertens.
1993;
11
647-655
-
12
Floras J S.
Epinephrine
and the genesis of hypertension.
Hypertension.
1992;
19
1-18
-
13
Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G.
Dissociation between
muscle and skin sympathetic nerve activity in essential hypertension,
obesity, and congestive heart failure.
Hypertension.
1998;
31
64-67
-
14
Greenwood J P, Stoker J B, Mary D A.
Single-unit sympathetic discharge: quantitative
assessment in human hypertensive disease.
Circulation.
1999;
100
1305-1310
-
15
Hagbarth K E, Vallbo A B.
Pulse and respiratory
grouping of sympathetic impulses in human muscle-nerves.
Acta
Physiol Scand.
1968;
74
96-108
-
16
Kaye D M, Vaddadi G, Gruskin S L, Du X J, Esler M D.
Reduced myocardial nerve growth factor expression
in human and experimental heart failure.
Circ Res.
2000;
86
E80
-
17
Kimura S, Miura Y, Adachi M, Nezu M, Toriyabe S, Sugawara T, Ishizuka Y, Noshiro T, Takahashi M. et al .
The effect of sodium depletion on plasma
norepinephrine kinetics in patients with essential hypertension.
Jpn
Circ J.
1983;
47
1232-1241
-
18
Kopf D, Lehnert H.
Prädiktive Untersuchungen
bei phänotypisch gesunden Nachkommen von Patienten mit
einem metabolischen Syndrom.
Dtsch Med Wochenschr.
2001;
126
235-240
-
19
Light K C, Koepke J P, Obrist P A, Willis P Wt.
Psychological
stress induces sodium and fluid retention in men at high risk for
hypertension.
Science.
1983;
220
429-431
-
20
Macefield V G, Wallin B G, Vallbo A B.
The discharge behaviour of single vasoconstrictor
motoneurones in human muscle nerves.
J Physiol.
1994;
481
799-809
-
21
Majewski H, Rand M J, Tung L H.
Activation of prejunctional beta-adrenoceptors
in rat atria by adrenaline applied exogenously or released as a
co-transmitter.
Br J Pharmaco.
1981;
73
669-679
-
22
Rumantir M S, Jennings G L, Lambert G W, Kaye D M, Seals D R, Esler M D.
The ‘adrenaline
hypothesis’ of hypertension revisited: evidence for adrenaline
release from the heart of patients with essential hypertension.
J
Hypertens.
2000;
18
717-723
-
23
Rumantir M S, Kaye D M, Jennings G L, Vaz M, Hastings J A, Esler M D.
Phenotypic
evidence of faulty neuronal norepinephrine reuptake in essential
hypertension.
Hypertension.
2000;
36
824-829
-
24
Runkel F, Bruss M, Nothen M M, Stober G, Propping P, Bonisch H.
Pharmacological properties
of naturally occurring variants of the human norepinephrine transporter.
Pharmacogenetics.
2000;
10
397-405
-
25
Schneider M P, Klingbeil A U, Schlaich M P, Langenfeld M R, Veelken R, Schmieder R E.
Impaired
sodium excretion during mental stress in mild essential hypertension.
Hypertension.
2001;
37
923-927
-
26
Shannon J R, Flattem N L, Jordan J, Jacob G, Black B K, Biaggioni I, Blakely R D, Robertson D.
Orthostatic intolerance
and tachycardia associated with norepinephrine- transporter deficiency.
N
Engl J Med.
2000;
342
541-549
-
27
Sherer T B, Neff P S, Hankins G R, Tuttle J B.
Mechanisms
of increased NGF production in vascular smooth muscle of the spontaneously
hypertensive rat.
Exp Cell Res.
1998;
241
186-193
-
28
Stober G, Nothen M M, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P.
Systematic search for
variation in the human norepinephrine transporter gene: identification
of five naturally occurring missense mutations and study of association
with major psychiatric disorders.
Am J Med Genet.
1996;
67
523-532
-
29
Wallin B G, Esler M, Dorward P, Eisenhofer G, Ferrier C, Westerman R, Jennings G.
Simultaneous
measurements of cardiac noradrenaline spillover and sympathetic
outflow to skeletal muscle in humans.
J Physio.
1992;
453
45-58
-
30
Wallin B G, Thompson J M, Jennings G L, Esler M D.
Renal
noradrenaline spillover correlates with muscle sympathetic activity
in humans.
J Physiol (Lond).
1996;
491
881-887
-
31
Yamada Y, Miyajima E, Tochikubo O, Matsukawa T, Ishii M.
Age-related
changes in muscle sympathetic nerve activity in essential hypertension.
Hypertension.
1989;
13
870-877
-
32
Zettler C, Rush R A.
Elevated concentrations
of nerve growth factor in heart and mesenteric arteries of spontaneously
hypertensive rats.
Brain Res.
1993;
614
15-20
Dr. Markus P. Schlaich
Baker Heart Research Institute
PO Box 6492
St Kilda Road Central
Melbourne Vic 8008
Australia
Phone: 61/3/85321343
Fax: 61/3/85321100
Email: markus.schlaich@baker.edu.au
